The 42nd Expert Committee on Drug Dependence will convene from 21st-25th October to review the public health harms, abuse and dependence liability of psychoactive substances as well as their therapeutic use. WHO makes recommendations to the Commission on Narcotic Drugs about the placement of psychoactive substances under international control. An Open Session will be held on 21st October to give the opportunity for individuals and partners external to the WHO to listen to an update on current and future activities of the ECDD Secretariat, and to provide comment on issues on the ECDD agenda.
As a followup to the 41st ECDD meeting held in 2018, WHO presented its recommendations for the proposed scheduling of cannabis and cannabis-related substances at the fourth intersessional of the 62nd CND.
Information can be found here.
96%Approximately 96% of the worldwide use of opioid analgesics is consumed in countries with only 15% of the world populationRead more...
75%of the world population, predominantly in lower-income countries, is left with limited or no access to proper pain reliefRead more...
8% less than 8% of people in need of palliative care have access to it.
International Drug Control Conventions
Controlled substances and public health
- WHO endorses decisions of Expert Committee on cannabis and other substances
- WHO Expert Committee on Drug Dependence meets to review cannabis and other substances
- 5th WHO - UNODC Expert Consultation on New Psychoactive Substances
- WHO recommends that pure cannabidiol (CBD) preparations should not be subject to international control
- 61st session of CND, video message by Dr. Tedros Adhanom Ghebreyesus, Director-General of WHO
- WHO recommends the most stringent level of international control for synthetic opioid carfentanil
- A joint commitment to effectively addressing and countering the world drug problem